Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/24/24 16:04 | 9/20/24 | CRBP | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | T | P | 7,004 | 20.01 | 0 | 350 | 17 | 2,375 | I | |||||||||||||||
3/11/24 17:34 | 3/7/24 | CRBP | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | T | P.m | 23,328 | 42.41 | 0 | 550 | 37 | 2,025 | I | |||||||||||||||
2/6/24 16:00 | 2/2/24 | CRBP | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | T | P | 14,250 | 19.00 | 0 | 750 | 103 | 1,475 | I | |||||||||||||||
1/30/24 16:23 | 1/26/24 | CRBP | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | T | P | 9,112 | 32.24 | 0 | 283 | 64 | 725 | I | |||||||||||||||
8/12/22 09:43 | 8/10/22 | CRBP | Health | Drug | Pharmaceutical Preparations | Millian Craig Stuart | MA | O | COO | P | 1 | 0.2545 | 0 | 5 | 23 | 27 | D | ||||||||||||||
8/11/22 09:55 | 8/10/22 | CRBP | Health | Drug | Pharmaceutical Preparations | Cohen Yuval | MA | DO | CEO | P | 1 | 0.2640 | 0 | 4 | 4 | 98 | D | ||||||||||||||
8/10/22 10:16 | 8/10/22 | CRBP | Health | Drug | Pharmaceutical Preparations | Moran Sean F. | MA | O | CFO | P | 5 | 0.2599 | 0 | 20 | 11 | 199 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |